Press Releases
Stay up to date with press releases covering announcements, company news, product launches, and business updates.
Publish your press release
Cutaneous T-Cell Lymphoma Clinical Trial Pipeline Accelerates as 30+ Pharma Companies Rigorously Developing Drugs for Market Entry | DelveInsight
GlobeNewswire, Inc.
New York, USA, May 21, 2026 (GLOBE NEWSWIRE) -- Cutaneous T-Cell Lymphoma Clinical Trial Pipeline Accelerates as 30+ Pharma Companies Rigorously Developing Drugs for Market Entry | DelveInsight The cutaneous T-cell lymphoma clinical trial analysis...
pMD® Completes Annual SOC 2® Type II and HIPAA Security Audits
GlobeNewswire, Inc.
SAN FRANCISCO, Oct. 02, 2026 (GLOBE NEWSWIRE) -- pMD®, a leading healthcare technology company, today announced it has successfully completed its annual SOC 2® Type II and HIPAA security audits, reaffirming its ongoing investment in protecting...
IPIM Organises the Life Sciences Delegation to São Paulo, Brazil for Business Exchange Connecting International Business Opportunities and Promoting the Development of the Big Health Industry
Macao Government News
MACAU, May 22 - To further leverage Macao's unique advantages as a platform for exchange and co-operation between China and Portuguese-speaking countries, promote life sciences enterprises from Macao and the Chinese mainland to expand into...
Peptide-Based Health Industry Positioned for Explosive Long-Term Growth Across Global Wellness Markets
GlobeNewswire, Inc.
NEW YORK, May 21, 2026 (GLOBE NEWSWIRE) -- Market News Updates News Commentary - The market for peptide-based health and performance products has been growing fast as more consumers focus on fitness, recovery, longevity, weight management, and...
Sepsis Clinical Trial Pipeline Appears Robust With 25+ Key Pharma Companies Actively Working in the Therapeutics Segment | DelveInsight
GlobeNewswire, Inc.
New York, USA, May 12, 2026 (GLOBE NEWSWIRE) -- Sepsis Clinical Trial Pipeline Appears Robust With 25+ Key Pharma Companies Actively Working in the Therapeutics Segment | DelveInsight The sepsis clinical trial analysis report delivers important...
Chair File: Leadership Dialogue — Redesigning the Primary Care Model With David Banks of AdventHealth
American Hospital Association
00:00:00:04 - 00:00:20:02 Tom Haederle Welcome to Advancing Health.
HRSA awards nearly $90 million for addiction, recovery services in rural areas
American Hospital Association
The Health Resources and Services Administration announced Sept. 25 that it awarded $89.3 million in grants to expand access to substance use disorder prevention, treatment and recovery services in rural communities nationwide.
Corbus Pharmaceuticals Appoints Pharma Industry Veteran Brent Pfeiffenberger to Board of Directors
GlobeNewswire, Inc.
NORWOOD, Mass., May 14, 2026 (GLOBE NEWSWIRE) -- Corbus Pharmaceuticals Holdings, Inc. (NASDAQ: CRBP), a clinical-stage company focused on developing promising new therapies in oncology and obesity, today announced the appointment of Brent...
Veterinary Healthcare Industry Analysis: Market Competition and Future Outlook
EIN Presswire
The Business Research Company's Veterinary Healthcare Industry Analysis: Market Competition and Future Outlook LONDON, GREATER LONDON, UNITED KINGDOM, May 6, 2026 /EINPresswire.com/ -- "The veterinary healthcare sector has seen remarkable growth...
PARP Inhibitors Clinical Trial Pipeline Accelerates as 25+ Pharma Companies Rigorously Develop Drugs for Market Entry | DelveInsight
GlobeNewswire, Inc.
New York, USA, May 07, 2026 (GLOBE NEWSWIRE) -- PARP Inhibitors Clinical Trial Pipeline Accelerates as 25+ Pharma Companies Rigorously Develop Drugs for Market Entry | DelveInsight The PARP inhibitor clinical trial analysis report delivers...
The Medical Plastic Extrusion Market is Projected to Reach $6.82 Billion by 2030 Driven by Robust Industry Expansion
EIN Presswire
The Business Research Company's The Medical Plastic Extrusion Market is Projected to Reach $6.82 Billion by 2030 Driven by Robust Industry Expansion LONDON, GREATER LONDON, UNITED KINGDOM, October 2, 2026 /EINPresswire.com/ -- "The medical...
Anemia and Blood Disorder Medications Industry Report: Market Competition and Future Outlook
EIN Presswire
The Business Research Company’s Anemia and Blood Disorder Medications Global Market Report 2026 – Market Size, Trends, And Forecast 2026-2035 LONDON, GREATER LONDON, UNITED KINGDOM, May 7, 2026 /EINPresswire.com/ -- Understanding the expanding...
Biz4Group LLC Emerges as a Top AI Healthcare Solutions Provider, Setting New Benchmarks in the U.S. Healthcare Industry
EIN Presswire
Biz4Group LLC is a trusted AI healthcare solutions provider delivering HIPAA-compliant software for hospitals, clinics, and health-tech firms across the USA. ORLANDO, FL, UNITED STATES, April 22, 2026 /EINPresswire.com/ -- Biz4Group LLC, a...
Nutriband Marks Five Years on Nasdaq – CEO Letter to Shareholders
GlobeNewswire, Inc.
Nutriband CEO Gareth Sheridan Congratulates Shareholders on Five-Year Nasdaq Listing Anniversary CEO letter reflects on five years of milestones since the Company's October 1, 2021 uplisting, as AVERSA™ Fentanyl advances toward an IND filing and...
Ubamatamab (MUC16xCD3) Shows a High Rate of Durable Responses in Initial Study of Patients with Advanced Low-Grade Serous Ovarian Cancer (LGSOC)
GlobeNewswire, Inc.
LGSOC is a biologically distinct variant of ovarian cancer, with limited treatment options, that is generally less responsive to conventional chemotherapy Results presented in a late-breaking plenary session at IGCS demonstrated a 73% objective...
InflaRx Appoints Gabriela Alperovich, MD, PhD, as Senior Vice President & Global Head of Clinical Development
GlobeNewswire, Inc.
Jena, Germany, Oct. 01, 2026 (GLOBE NEWSWIRE) -- InflaRx N.V. (Nasdaq: IFRX), a biopharmaceutical company pioneering anti-inflammatory therapeutics by targeting the complement system, today announced the appointment of Gabriela Alperovich, MD,...
Phase 2 COURAGE Trial Confirms Trevogrumab Prevents Lean Mass and Muscle Loss During GLP-1 Receptor Agonist-induced Weight Loss
GlobeNewswire, Inc.
In a predefined MRI substudy, trevogrumab prevented 70% of muscle loss associated with semaglutide treatment A pre-specified subgroup analysis found that patients meeting the low lean mass definition for sarcopenia had greater loss of lean mass...
Loyd Resignation Raises Serious Questions about Morrisey Administration’s Drug Policy
West Virginia Democratic Party
For Immediate Release October 1, 2026 Loyd Resignation Raises Serious Questions about Morrisey Administration’s Drug Policy CHARLESTON, W.Va. — West Virginia Democratic Party Chairman Mike Pushkin today expressed deep concern over the resignation...
Renaissance Pharma Limited, an Essential Pharma company, secures FDA Fast Track Designation and IND clearance for Daretabart (hu1418K322A) in high-risk neuroblastoma
GlobeNewswire, Inc.
FDA grants Fast Track Designation for Daretabart (hu1418K322A), recognising the significant unmet medical need in high-risk neuroblastoma and enabling access to accelerated and rolling review FDA clearance of IND application enables initiation of...
Severe Asthma Clinical Trial Pipeline Appears Robust With 30+ Key Pharma Companies Actively Working in the Therapeutics Segment | DelveInsight | DelveInsight
GlobeNewswire, Inc.
New York, USA, April 07, 2026 (GLOBE NEWSWIRE) -- Severe Asthma Clinical Trial Pipeline Appears Robust With 30+ Key Pharma Companies Actively Working in the Therapeutics Segment | DelveInsight | DelveInsight The severe asthma clinical trial...
Sign up for:
Medical Industry Today
The daily local news briefing you can trust. Every day. Subscribe now.
Check Your Email!
We sent a one-time activation link to: .
Confirm it's you by clicking the email link.
If the email is not in your inbox, check spam or try again.
Welcome back!
is already signed up. Check your inbox for updates.